You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 113 No. 2, February 1977 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL CONTRIBUTIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (65)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Phagocyte Function and Cell-Mediated Immunity in Systemic Lupus Erythematosus

Madeleine Landry, MD

Arch Dermatol. 1977;113(2):147-154.


Abstract



• Lymphocyte, granulocyte, and macrophage function were studied simultaneously in 26 untreated patients with systemic lupus erythematosus (SLE) and 26 matched controls. The overall cellular response, as assessed in vivo by skin tests and sensitization to dinitrochlorobenzene, was diminished in the SLE group. Although T cells were reduced in number in patients with SLE, their function appeared unimpaired, as shown by normal lymphocyte transformation to phytohemagglutinin and bacterial and fungal antigens. The depressed cutaneous reactivity observed in vivo was explained by the finding of major deficits in the efferent limb of cellular immunity. Initial rate of phagocytosis of both polymorphonuclear neutrophils and macrophages was significantly reduced in patients with SLE as compared with normal persons. Because of cell interaction, the presence of an intrinsic macrophage defect in SLE may contribute to the alleged T- and B-cell dysfunction in that disease.

(Arch Dermatol 113:147-154, 1977)



Author Affiliations



From the Clinical Research Institute of Montreal, Montreal.


Footnotes



Accepted for publication July 13, 1976.

Reprint requests to Hopital Hotel-Dieu, 3840 St-Urbain, Montreal, Quebec, Canada (Dr Landry).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

SLE--a disease of clearance deficiency?
Munoz et al.
Rheumatology (Oxford) 2005;44:1101-1107.
ABSTRACT | FULL TEXT  

TNF-related apoptosis-inducing ligand is involved in neutropenia of systemic lupus erythematosus
Matsuyama et al.
Blood 2004;104:184-191.
ABSTRACT | FULL TEXT  

Systemic lupus erythematosus and gouty arthritis: an uncommon association
Bajaj et al.
Rheumatology (Oxford) 2004;43:349-352.
ABSTRACT | FULL TEXT  

Letter to the Editor
Moosig et al.
Lupus 2003;12:490-493.
 

Monoclonal anti-double stranded DNA antibody is a leucocyte-binding protein to up-regulate interleukin-8 gene expression and elicit apoptosis of normal human polymorphonuclear neutrophils
Hsieh et al.
Rheumatology (Oxford) 2001;40:851-858.
ABSTRACT | FULL TEXT  

Role of Macrophage Lysosomal Enzymes in the Degradation of Nucleosomes of Apoptotic Cells
Odaka and Mizuochi
J. Immunol. 1999;163:5346-5352.
ABSTRACT | FULL TEXT  

Mechanism-Oriented Assessment of Isotretinoin in Chronic or Subacute Cutaneous Lupus Erythematosus
Newton et al.
Arch Dermatol 1986;122:170-176.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1977 American Medical Association. All Rights Reserved.